Land: Irland
Sprache: Englisch
Quelle: HPRA (Health Products Regulatory Authority)
ROMIFIDINE HYDROCHLORIDE
Virbac S.A.
QN05CM93
1 Mg/Ml
Solution for Injection
Neurological Preparations
Canine
2001-04-06
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT ROMIDYS 1 mg/ml solution for injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Romidys 1 mg/ml solution for injection contains : ACTIVE INGREDIENT Romifidine hydrochloride 1 mg equivalent to 0.876 mg romifidine PRESERVATIVES Methyl parahydroxybenzoate (E218) 1.8 mg Propyl parahydroxybenzoate (E216) 0.2 mg 3 PHARMACEUTICAL FORM Solution for injection. Clear almost colorless solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Sedative for use in dogs and cats for restraint; to facilitate handling, clinical examinations, minor surgical interventions and manipulations. Premedication agent prior to the induction of general anaesthesia. For profound sedation/analgesia in dogs it may also be used with an opioid analgesic. In cats combination with ketamine provides surgical anaesthesia. 4.3 CONTRAINDICATIONS Do not use in pregnant animals. Do not use in animals suffering from diabetes mellitus 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES As a dose-dependent increase in blood urea may occur in cats, sufficient fluid intake should be ensured. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 19/04/2011_ _CRN 7008367_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Sedated animals should be restrained to prevent injury. Care should be taken to ensure that animals have sufficient fluid intake. Animals, which undergo prolonged sedation, should be prevented from becoming hypothermic. Care should be taken in animals in poor health, or in cases of cardiovascular, renal, hepatic or pancreatic disease, and in animals sufferi Lesen Sie das vollständige Dokument